Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma-Reference-Cited by-同舟云学术

Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma

Published:2009-05-01 Issue:9 Volume:115 Page:1906-1913
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Luminari Stefano,Marcheselli Luigi,Sacchi Stefano,Pozzi Samantha,Bari Alessia,Ilariucci Fiorella,Stelitano Caterina,Angrilli Francesco,Lazzaro Antonio,Baldini Luca

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference20 articles.

1. Current controversies in follicular lymphoma;Aurora;Blood Rev.,2006

2. t(14;18), a journey to eternity;Meijerink;Leukemia.,1997

3. Follicular lymphoma: prognostic factors for response and survival;Gallagher;J Clin Oncol.,1986

4. Natural history of and therapy for the indolent non-Hodgkin's lymphomas;Horning;Semin Oncol.,1993

5. Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients;Sacchi;Cancer.,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies;The AAPS Journal;2017-02-21

2. Comparison on therapeutic effects of RFT and RCTVP regimen in the treatment of patients with indolent B-cell lymphoma in China;Medical Oncology;2012-03-20

3. Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: An Updated Systematic Review and Meta-analysis of Randomized Trials;JNCI: Journal of the National Cancer Institute;2011-12-07

4. Antibiotic Management of Febrile Neutropenia: Current Developments and Future Directions;Journal of Chemotherapy;2010-02

5. A Limited Sampling Schedule to Estimate Individual Pharmacokinetic Parameters of Fludarabine in Hematopoietic Cell Transplant Patients;Clinical Cancer Research;2009-08-11